Skip to main content
Rui Zhong on Muck Rack

Rui Zhong

As seen in: Medium, MSN, Nature, The Washington Post, Wiley Online Library, PLOS ONE, WIRED Magazine, Elsevier, Fixing the Future, Frontiers and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Rui

Contact Rui, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

S-BGM: Stable Self-Evolving LLMs via Cognitive Bipartite Graph Modeling

|
By Songyang Liu, Chaozhuo Li, Rui Zhong
| preprints.org
You are already at the latest version Self-evolving LLMs that iteratively train a problem-generating Questioner and a problem-solving Solver present a promising path toward reducing human supervision. Existing approaches optimize each role independently with short-term, separate rewards, neglecting the co-evolutionary dynamics of the Questioner–Solver system as a whole. This leads to model collapse, where the Solver’s performance plateaus or degrades after only a few iterations.
Open in Who Shared Issue with article?

Morphological abnormalities in the ureter of type XVII collagen–deficient mice

|
By Takashi Namba, Masaya Hiraishi, Shunnosuke Kira, Yuki Otani, Rui Zhong, Ken Natsuga, Osamu Ichii, Amy Suzui
| Nature Verified
Abstract Non-fibrillar type XVII collagen (COL17A1) is a hemidesmosomal component of the epidermis and a key skin-disease molecule. We previously reported that COL17A1 is expressed in the urothelium of multiple species at low constitutive or in inducible levels. To clarify its function in the ureter, Col17a1-knockout (KO) mice were examined from 2 to 12 weeks of age.
Open in Who Shared Issue with article?

Model‐Informed Abatacept Dose Recommendation in Pediatric Patients With Acute Graft Versus Host Disease

|
By Rui Zhong, Kelly Maxwell, Julie Passarell
| Wiley Online Library Verified
Introduction Allogeneic hematopoietic stem cell transplantation (HSCT) is an effective treatment for aggressive leukemias and other hematologic malignancies (HMs), often representing the only option for cure.
Open in Who Shared Issue with article?
See all 121 licensed articles (126 Total)